
|Articles|January 13, 2020
Labcorp And Covance Launch Cell and Gene Therapy Development Solutions
Advertisement
LabCorp has introduced its focused and coordinated suite of cell and gene therapy development solutions from Covance. These solutions are designed to reduce time and risk for sponsors at each phase and across the full continuum of their therapy development.
To get more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
4
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
5




